已收录 268921 条政策
 政策提纲
  • 暂无提纲
Genetic Factors for Warfarin Dose Prediction
[摘要] Warfarin, a commonly prescribed anticoagulant drug used to prevent thrombosis, has a narrow therapeutic range, and small dose variations may result in hemorrhagic or thrombotic complications. The 2 key enzymes in the metabolism of warfarin are cytochrome P450 (CYP) 2C9 ( CYP2C9 gene) and the C1 subunit of the vitamin K 2,3 epoxide reductase complex ( VKORC1 gene). CYP2C9 accounts for up to 85% of the metabolism of the pharmacologically more potent S-warfarin enantiomer, and VKORC1, the 2nd key enzyme in warfarin metabolism, is responsible for recycling reduced vitamin K. In their recent article, Zhu et al. (1) concluded that genotyping both VKORC1 …
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 过敏症与临床免疫学
[关键词]  [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文